When it comes to mRNA injections for Covid, Americans are 100% dependent on the FDA and vaccine manufacturers to assess and confirm purity and consistency. That might be okay if the testing methodologies that manufacturers and the FDA were still fully transparent, but they’re not anymore.
Not only are the test results confidential, even the methodology used hasn’t been made public. The world just has to take manufacturers’ word that there’s no contamination or variability with the mRNA sequence or its lipid nanoparticle components – even though published epidemiology data indicate otherwise.
Secrecy abounds despite the vaccine manufacturers receiving billions of U.S. taxpayer dollars to conduct their R&D efforts. Transparency should be nonpartisan, especially when it comes to the quality of America’s pharmaceuticals.
On top of that, both the Trump and Biden administrations have proposed lifting Covid mRNA intellectual property rights for mRNA injections. Yet both the FDA and manufacturers are tightly protecting the ingredient information as proprietary or a trade secret. But is it really appropriate to label it “proprietary/trade secret” if the research, development and product were funded with hundreds of millions of taxpayer dollars?
A transparent, publicly accountable FDA should be eager to prospectively test most or all of its regulated products for qualitative and quantitative consistency – and make those findings publicly available.
A transparent FDA would also share its testing methodology for mRNA Covid products for scientists who wish to confirm. But anyone trying to access this information will find it embargoed via an FDA report rendered useless by ludicrous redactions of not just the methodology, but the FDA’s critique of the methodology.